We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNRX icon
4501
VolitionRx Ltd
VNRX
$6.47M
$9K ﹤0.01%
148
-50
-25% -$2.83K
VUG icon
4502
Vanguard Morningstar Growth ETF
VUG
$230B
$9K ﹤0.01%
192
– –
WNS
4503
DELISTED
WNS Holdings
WNS
$9K ﹤0.01%
109
-1,676
-94% -$143K
YI
4504
111 Inc
YI
$32.3M
$9K ﹤0.01%
322
-94
-23% -$2.73K
ZH
4505
Zhihu
ZH
$273M
$9K ﹤0.01%
651
+627
+2,613% +$13.5K
ZVIA icon
4506
Zevia
ZVIA
$102M
$9K ﹤0.01%
2,050
+595
+41% +$4.14K
GPUS
4507
Hyperscale Data Inc
GPUS
$43.2M
– –
0
– –
VOXX
4508
DELISTED
VOXX International Corporation Class A
VOXX
$9K ﹤0.01%
906
-76
-8% -$811
VIRX
4509
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$9K ﹤0.01%
1,873
-4,518
-71% -$13.6K
FREE
4510
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$9K ﹤0.01%
1,156
+86
+8% +$770
MAQC
4511
DELISTED
Maquia Capital Acquisition Corporation Class A Common Stock
MAQC
$9K ﹤0.01%
900
+826
+1,116% +$8.33K
AKLI
4512
DELISTED
Akili Inc
AKLI
$9K ﹤0.01%
876
-92
-10% -$907
SWSSU
4513
DELISTED
Clean Energy Special Situations Corp. Unit
SWSSU
$9K ﹤0.01%
1,738
-144
-8% -$721
KAMN
4514
DELISTED
Kaman Corp
KAMN
$9K ﹤0.01%
200
-435
-69% -$18.4K
KNTE
4515
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$9K ﹤0.01%
788
-545
-41% -$6K
BKCC
4516
DELISTED
BlackRock Capital Investment Corporation
BKCC
$9K ﹤0.01%
2,107
-1,138
-35% -$4.7K
CCVI.U
4517
DELISTED
Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CCVI.U
$9K ﹤0.01%
862
+10
+1% +$99
AEY
4518
DELISTED
ADDvantage Technologies Group
AEY
$9K ﹤0.01%
605
-195
-24% -$2.58K
AAC.U
4519
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$9K ﹤0.01%
923
+553
+149% +$5.45K
BTWN
4520
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$9K ﹤0.01%
866
-4,107
-83% -$40.4K
ANZUU
4521
DELISTED
Anzu Special Acquisition Corp I Units
ANZUU
$9K ﹤0.01%
910
-2
-0.2% -$20
ADER
4522
DELISTED
26 Capital Acquisition Corp
ADER
$9K ﹤0.01%
933
+351
+60% +$3.46K
CPUH
4523
DELISTED
Compute Health Acquisition Corp.
CPUH
$9K ﹤0.01%
932
-335
-26% -$3.27K
NMTR
4524
DELISTED
9 Meters Biopharma
NMTR
$9K ﹤0.01%
766
+158
+26% +$2.16K
LABP
4525
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$9K ﹤0.01%
597
+200
+50% +$5.09K
179 180
181
182 183

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.